Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
magazineAstraZeneca among first names in FTSE 100 reporting season
Thursday 2 February
Pharma stock AstraZeneca (AZN) will become one of the first big FTSE 100 stocks to report 2016 earnings when its figures are published on 2 February. Look for an update on R&D spend, a priority for the newly installed management, and sales performance. Group sales fell 5% to $17.4bn in the first nine months of 2016.
Important information:
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell Youinvest.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
